Chart Rhythms

Follow the rhythm behind every market move.

News Center

Source articles powering Chart Rhythms.

Browse cached source articles used by the rhythm engine. Filter by ticker, sentiment, or keyword, then open the stock rhythm page for deeper daily, swing, and long-term analysis.

Cached Articles

33165

Tickers With News

515

Showing Now

Top Ticker

AAPL

Active filters:

Ticker: ASentiment: NEUTRALClear filters

Featured Tickers

Quick rhythm news shortcuts.

Jump straight into the most important tickers for testing and market coverage.

Search all stocks

JPM MA VEEV FICO NVDA AAPL MSFT TSLA

Ticker Filters

Browse by cached coverage.

These are the tickers with the most cached source articles right now.

Search all stocks

All AAPL: 656 TSLA: 645 F: 584 C: 574 MSFT: 458 NVDA: 391 JPM: 380 MA: 363 AMD: 309

49 source articles found.

Open Markets

ANeutralSeekingAlpha • 2026-08-16Cached source

Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside

Open Source Open Stock Rhythm

ANeutralSeekingAlpha • 2026-08-14Cached source

Danaher: 2027 Growth Reacceleration Should Drive Upside

Open Source

Loading Chart Rhythms

Source articles powering Chart Rhythms.

Quick rhythm news shortcuts.

Browse by cached coverage.

49 source articles found.

Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside

Danaher: 2027 Growth Reacceleration Should Drive Upside

Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $175

[Latest] Global gRNA Market Size/Share Worth USD 2950 Million by 2034 at a 19% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates

Agilent Technologies (A) Secures Expanded EU Approval For Ovarian Cancer Test

Are Options Traders Betting on a Big Move in Agilent Technologies Stock?

Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?

Envista (NVST) Q2 Earnings and Revenues Surpass Estimates

If You Invested $1000 in Keysight a Decade Ago, This is How Much It'd Be Worth Now

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?

Solventum to Report Q2 Earnings: What's in Store for the Stock?

Thermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results

6 Health Care Stocks Whale Activity In Today’s Session

Agilent Technologies (A) Expands Its Oncology Diagnostics Reach—Can Growth Keep Up?

How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends

Revvity to Report Q2 Earnings: What's in Store for the Stock?

Avantor Stock Surged Because One Segment Stopped Shrinking

Stryker (SYK) Q2 Earnings and Revenues Beat Estimates

Is Argenx (ARGX) Outperforming Other Medical Stocks This Year?

Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo

Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26

[Latest] Global Precision Diagnostics And Medicine Market Size/Share Worth USD 345.75 Billion by 2035 at a 8.91% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

DXCM Q2 Results Likely to Reflect Strong G7 & Reimbursement Expansion

Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test

Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics?

Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?

Reading Between The Lines Of DHR's Latest Call

Will Baxter's Q2 Results Continue to Reflect Operational Headwinds?

1 Healthcare Stock to Research Further and 2 We Avoid

What to Expect From Agilent Technologies' Q3 2026 Earnings Report

Agilent Technologies shares are trading higher after the company announced it has received EU certification for PD-L1 IHC 22C3 pharmDx, in identifying epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.

In Vitro Toxicology Testing Market to Exceed $20.97 Billion by 2031 as Non-Animal Testing & AI Adoption Accelerate - Analysis by Product, Toxicity Endpoints & Type, Technology, Method, Service, Region

Agilent Technologies Receives EU Certification For Code SK006 As Companion Diagnostic To Aid In Identifying Patients With Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Carcinoma

Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Get insights into the top movers in the S&P500 index of Tuesday's pre-market session.

Agilent Increases Its Investment in HALO X-ray Technologies

Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate

Dividend Champion, Contender, And Challenger Highlights: Week Of July 19

Agilent Technologies (NYSE:A) Shows Strong Breakout Setup with Top-Tier Technical Ratings

1 of Wall Street’s Favorite Stocks on Our Buy List and 2 We Brush Off

Agilent Receives FDA Approval For The PD‑L1 LHC 28‑8 PharmDx Assay As Companion Diagnostic To Identify Patients With Carcinomas Who May Be Eligible For Treatment With OPDIVO or OPDIVO QVANTIG

Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma

Agilent (A): Buy, Sell, or Hold Post Q1 Earnings?

Alamar Hits A High Note On Alzheimer's Buzz

Nuvalent Inc. (NUVL) — GSK’s Harmony Row clears HSR; $124 cash offer proceeds

Illumina: While You Chased AI, This Healthcare Stock Built A $30B Moat

BenchSci Names Former Pfizer R&D Chief Dr. Mikael Dolsten as Chairman of the Board